Viewing Study NCT00126802


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-01-25 @ 12:11 AM
Study NCT ID: NCT00126802
Status: UNKNOWN
Last Update Posted: 2016-07-06
First Post: 2005-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer
Sponsor: AHS Cancer Control Alberta
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GU-06-0052/ethics 21781
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators